Latest from PAN
Connect with your elected officials this August
Congress is scheduled to be on summer recess August 3 - September 8, and Members of Congress will be returning home to their states and districts. Learn more. 
Researcher advocates play crucial role in conversations about biomedical research funding
Over the last year, the health advocacy community has seen an increase in efforts to involve researchers in advocacy and outreach and the Parkinson’s Action Network (PAN) is no exception. Learn more.
Take Action With PAN!
Please contact your Members of Congress  and ask them to co-sponsor the Medicare Access to Rehabilitation Services Act of 2013 (H.R. 713/S. 367).
Encourage your Members of Congress  to join the Congressional Caucus on Parkinson’s Disease and increase political leadership for the Parkinson’s community on Capitol Hill.
In The News
The doctor is always in
DelmarvaNow.com | July 15, 2013
For people with Parkinson’s, having access to care from someone who understands the nuances of the disease can make all the difference. More… 
Norman doctor honored by Michael J. Fox for fundraising efforts
NewsOK.com | July 16, 2013
Michael J. Fox has lived with Parkinson's disease for more than 20 years and, though the disease has affected Fox's mobility and speech, he continues to thrive with the help of medication, enough so to launch his own new TV sitcom, “The Michael J. Fox Show,” this fall. More… 
Responsive brain stimulation could improve life for Parkinson's sufferers
MedicalXpress.com | July 15, 2013
Researchers in Oxford have demonstrated a significant improvement in the treatment of advanced Parkinson's disease with deep brain stimulation. More… 
University Of California, San Diego School Of Medicine To Investigate Risk Factors For Parkinson's Disease Via Parkinson's Progression Markers Initiative (PPMI)
Wall Street Journal | July 15, 2013
University of California, San Diego School of Medicine will be one of 23 official clinical sites of the Parkinson's Progression Markers Initiative's (PPMI) new arm to study at-risk populations for Parkinson's disease (PD). More… 
After FDA Approval, Drugmakers Often Miss Study Mark
NPR | July 11, 2013
The prescription drugs you take spend plenty of time on the drawing board before they end up in your medicine cabinet. But the research work doesn't necessarily stop then. More… 
Dementia Rate Is Found to Drop Sharply, as Forecast
New York Times | July 16, 2013
A new study has found that dementia rates among people 65 and older in England and Wales have plummeted by 25 percent over the past two decades, to 6.2 percent from 8.3 percent, a trend that researchers say is likely occurring across developed countries and that could have major social and economic implications for families and societies. More…